Reported Jan 12, 2022 · Terminated
Cefixime 400 mg capsule, packaged in a) 2-count bottle (NDC 70518-2749-02), b) 2-count blister pack (NDC…
RemedyRepack Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: RemedyRepack Inc. · 625 Kolter Dr Ste 4 · Indiana, PA · 15701-3571
Is this the product you have?
- Cefixime 400 mg capsule, packaged in a) 2-count bottle (NDC 70518-2749-02), b) 2-count blister pack (NDC 70518-2749-03), Rx only
- MFGAscend Labs, LLC, Montvale, NJ 07645
- Lot codes and dates
10 of 10 products
Products covered by this recall # Product as published 1 B1429436-110821, Exp 07/2022 2 B1429434-110821, Exp 11/2022 3 B1429435-110821, Exp 11/2022 4 B1279449-072021, Exp 07/2022 5 B1279457-072021, Exp 07/2022 6 B1279442-072021,Exp 07/2022 7 B1057718-012621, Exp 01/2022 8 B1057727-012621, Exp 01/2022 9 B1358139-092121, Exp 03/2022 10 B1424654-110421, B1437578-111421, Exp 05/2022 - Amount recalled
- a) 716 bottles/ 1432 capsules b) 223 blister packs/ 466 capsules
Where it was sold
Why it was recalled
Failed Impurities/Degradation Specifications
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new RemedyRepack Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.